Page last updated: 2024-09-05

gr 144053 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

gr 144053 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(gr 144053)
Trials
(gr 144053)
Recent Studies (post-2010)
(gr 144053)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
21129,156187552

Protein Interaction Comparison

ProteinTaxonomygr 144053 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heptinstall, S; Lösche, W; Sanderson, HM; Vickers, J1

Other Studies

1 other study(ies) available for gr 144053 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Azepines; Blood Platelets; Humans; In Vitro Techniques; Piperazines; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin; Succinates; Sulfonamides; Thromboxane A2; Triazoles; Vasoconstrictor Agents

1996